While Staar Surgical Co has overperformed by 2.80%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, STAA fell by -10.55%, with highs and lows ranging from $52.68 to $26.66, whereas the simple moving average fell by -17.95% in the last 200 days.
On July 15, 2024, Morgan Stanley Downgraded Staar Surgical Co (NASDAQ: STAA) to Underweight. A report published by BTIG Research on June 11, 2024, Upgraded its rating to ‘Buy’ for STAA. Stifel also Upgraded STAA shares as ‘Buy’, setting a target price of $50 on the company’s shares in a report dated March 11, 2024. Morgan Stanley initiated its ‘Equal-Weight’ rating for STAA, as published in its report on December 04, 2023. Canaccord Genuity also rated the stock as ‘Hold’.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Analysis of Staar Surgical Co (STAA)
Further, the quarter-over-quarter increase in sales is 10.31%, showing a positive trend in the upcoming months.
One of the most important indicators of Staar Surgical Co’s future performance is equity, which can be evaluated using several well-rounded types of analysis and research techniques. The goal here is to ensure that your current return on equity of 5.40% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 5.38, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can also provide valuable insight into volatility, and STAA is recording 800.70K average volume. On a monthly basis, the volatility of the stock is set at 4.58%, whereas on a weekly basis, it is put at 7.82%, with a gain of 4.65% over the past seven days. Furthermore, long-term investors anticipate a median target price of $43.12, showing growth from the present price of $30.86, which can serve as yet another indication of whether STAA is worth investing in or should be passed over.
How Do You Analyze Staar Surgical Co Shares?
The Medical Instruments & Supplies market is dominated by Staar Surgical Co (STAA) based in the USA. When comparing Staar Surgical Co shares with other companies under Healthcare, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 70.44, there is a growth in quarterly earnings of 105.64%.
Along with the fundamentals, it is also important to consider how many employees own shares of the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 0.67%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 91.94% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
STAA shares are owned by institutional investors to the tune of 91.94% at present.
